Actively Recruiting
Study of Nutritional Therapy and Infliximab Treatment in Children Aged 9 to 17 With Crohns Disease
Led by University of British Columbia · Updated on 2026-05-01
140
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the impact of combining a specialized nutritional therapy, the modified Crohns Disease Exclusion Diet mCDED, with the biologic drug infliximab in children aged 9 to 17 years diagnosed with moderate to severe active luminal Crohns disease. The goal is to improve treatment responses, reduce medication exposure, and support better long-term health outcomes for pediatric patients who often face growth issues and frequent hospitalizations due to this inflammatory bowel disease. This open-label, randomized controlled study aims to compare the effects of infliximab alone versus infliximab combined with mCDED over a year.
CONDITIONS
Brief Title
Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
Research Team
K
Kevan Jacobson, MBBCh, FRCP, FRCPC, AGAF, CAGF
F
Fanny Lemarie, MSc, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
